FNBT
GHDX

FineMark National Bank & Trust’s Genomic Health, Inc. GHDX Stock Holding History

FineMark National Bank & Trust’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-631
Closed -$18K – 1495
2013
Q4 		$18K Hold
631
– – ﹤0.01% 873
2013
Q3 		$19K Hold
631
– – ﹤0.01% 818
2013
Q2 		$20K Buy
+631
New +$20.7K 0.01% 790

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

FineMark National Bank & Trust's GHDX Position: Q1 2014 in Review

FineMark National Bank & Trust sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 631 shares — an estimated $18K sold.

FineMark National Bank & Trust first reported a position in GHDX in Q2 2013 and held it in 3 quarters. The position peaked at $20K in Q2 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • FineMark National Bank & Trust reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • FineMark National Bank & Trust sold 631 Genomic Health, Inc. shares in Q1 2014, an estimated $18K.
  • FineMark National Bank & Trust first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 3 quarters.
  • FineMark National Bank & Trust's Genomic Health, Inc. position peaked at $20K in Q2 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on FineMark National Bank & Trust's 13F filing for Q1 2014, filed 13 May 2014.